Literature DB >> 8322167

The design and development of an immunosuppressive drug, mycophenolate mofetil.

A C Allison1, E M Eugui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8322167     DOI： 10.1007/bf00192309

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  83 in total

1.  RS-61443 allows islet allografting and specific tolerance induction in adult mice.

Authors:  L Hao; K J Lafferty; A C Allison; E M Eugui
Journal:  Transplant Proc       Date:  1990-04       Impact factor: 1.066

Review 2.  The mode of action of anti-rheumatic drugs. 1. Anti-inflammatory and immunosuppressive effects of glucocorticoids.

Authors:  A C Allison; S W Lee
Journal:  Prog Drug Res       Date:  1989

3.  Control of phosphoribosylpyrophosphate synthesis in human lymphocytes.

Authors:  R C Garcia; P Leoni; A C Allison
Journal:  Biochem Biophys Res Commun       Date:  1977-08-08       Impact factor: 3.575

Review 4.  Purine metabolism and control of cell proliferation.

Authors:  T Hovi; A C Allison; K Raivio; A Vaheri
Journal:  Ciba Found Symp       Date:  1977

5.  Use of cyclosporin A in allogeneic bone marrow transplantation in the rat.

Authors:  P J Tutschka; W E Beschorner; A C Allison; W H Burns; G W Santos
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

6.  Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.

Authors:  R E Morris; J Wang; J R Blum; T Flavin; M P Murphy; S J Almquist; N Chu; Y L Tam; M Kaloostian; A C Allison
Journal:  Transplant Proc       Date:  1991-04       Impact factor: 1.066

7.  Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus.

Authors:  R Verham; T D Meek; L Hedstrom; C C Wang
Journal:  Mol Biochem Parasitol       Date:  1987-05       Impact factor: 1.759

8.  Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

Authors:  C J Green; A C Allison
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

9.  The inhibition of nucleic acid synthesis by mycophenolic acid.

Authors:  T J Franklin; J M Cook
Journal:  Biochem J       Date:  1969-07       Impact factor: 3.857

10.  Demonstration that a lectin-like receptor (gp90MEL) directly mediates adhesion of lymphocytes to high endothelial venules of lymph nodes.

Authors:  J S Geoffroy; S D Rosen
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539
View more
  21 in total

1.  A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Authors:  Elliot M Frohman; Gary Cutter; Gina Remington; Hongjiang Gao; Howard Rossman; Bianca Weinstock-Guttman; Jacqueline E Durfee; Amy Conger; Ellen Carl; Katherine Treadaway; Eric Lindzen; Amber Salter; Teresa C Frohman; Anjali Shah; Angela Bates; Jennifer L Cox; Michael G Dwyer; Olaf Stüve; Benjamin M Greenberg; Michael K Racke; Robert Zivadinov
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.

Authors:  Tim Ulinski; Laurence Dubourg; Marie Hélène Saïd; Bernadette Parchoux; Bruno Ranchin; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

Review 3.  Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

Authors:  Michel Mourad; Pierre Wallemacq; Josiane König; Evelyne Henry de Frahan; Djamila Chaib Eddour; Martine De Meyer; Jacques Malaise; Jean Paul Squifflet
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Population pharmacokinetics of mycophenolic acid in renal transplant recipients.

Authors:  Reinier M van Hest; Teun van Gelder; Arnold G Vulto; Ron A A Mathot
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats.

Authors:  Constantin Fotiadis; Paraskevi Xekouki; Apostolos E Papalois; Pantelis T Antonakis; Ioannis Sfiniadakis; Dimitrios Flogeras; Eleutheria Karampela; George Zografos
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 6.  Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Authors:  M Behrend
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.

Authors:  Jodi L Karnell; Fredrick G Karnell; Geoffrey L Stephens; Bhargavi Rajan; Chris Morehouse; Ying Li; Bonnie Swerdlow; Mildred Wilson; Raphaela Goldbach-Mansky; Christopher Groves; Anthony J Coyle; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

8.  Mycophenolic acid inhibits replication of Type 2 Winnipeg, a cerebrospinal fluid-derived reovirus isolate.

Authors:  Laura L Hermann; Kevin M Coombs
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

9.  Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Authors:  Flora T Musuamba; Annick Rousseau; Jean-Louis Bosmans; Jean-Jacques Senessael; Jean Cumps; Pierre Marquet; Pierre Wallemacq; Roger K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 10.  PharmGKB summary: mycophenolic acid pathway.

Authors:  Vishal Lamba; Katrin Sangkuhl; Kinjal Sanghavi; Alyssa Fish; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-01       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.